logo

Cassava Sciences Inc (SAVA)



Trade SAVA now with
  Date
  Headline
4/26/2022 10:52:35 AM Cassava Sciences Stock Gains 4%
4/5/2022 11:13:12 AM Cassava Sciences Slides 11%
9/22/2021 8:44:05 AM Cassava Sciences Announces Top-line Results Of 12-month Interim Analysis From Open-label Study Evaluating Simufilam
8/25/2021 7:35:56 AM Cassava Sciences Responds To Allegations; Stock Down
8/24/2021 8:36:38 AM Cassava Sciences Agrees With FDA On Special Protocol Assessments For Simufilam Phase 3 Studies For Alzheimer’s Disease
6/14/2021 8:36:01 AM Cassava Sciences Names Richard Barry To Board, Effective June 11